The TLR3 signaling complex forms by cooperative receptor dimerization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 1, 2008, Pages 258-263

  Leonard, Joshua N ^a   Ghirlando, Rodolfo ^b   Askins, Janine ^a   Bell, Jessica K ^d   Margulies, David H ^c   Davies, David R ^b   Segal, David M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

dsRNA; Innate immunity; Toll like receptors

Indexed keywords

DOUBLE STRANDED RNA; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 3;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN PURIFICATION;

BINDING SITES; BUFFERS; CELL LINE; CELL SEPARATION; CHROMATOGRAPHY, GEL; CROSS-LINKING REAGENTS; DIMERIZATION; DNA, SINGLE-STRANDED; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; LIGANDS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES; RNA, DOUBLE-STRANDED; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 38349115933     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0710779105     Document Type: Article

References (37)

1. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1-14.
2. Bell JK, et al. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol 24:528-533.
3. Mizel SB, West AP, Hantgan RR (2003) Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem 278:23624-23629.
4. Sato M, et al. (2003) Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol 171:417-425.
5. Cornelie S, et al. (2004) Direct evidence that Toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J Biol Chem 279:15124-15129.
6. Meng G, et al. (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113:1473-1481.
7. Rutz M, et al. (2004) Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence-and pH-dependent manner. Eur J Immunol 34:2541-2550.
8. Vasselon T, Detmers PA, Charron D, Haziot A (2004) TLR2 recognizes a bacterial lipopeptide through direct binding. J Immunol 173:7401-7405.
9. Bell JK, et al. (2005) The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 102:10976-10980.
10. Ranjith-Kumar CT, et al. (2007) Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J Biol Chem 282:7668-7678.
11. Choe J, Kelker MS, Wilson IA (2005) Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309:581-585.
12. Kim HM, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell 130:906-917.
13. Jin MS, et al. (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071-1082.
14. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of doublestranded RNA, activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
15. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR (2006) Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80:5059-5064.
16. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364-1369.
17. Matsumoto M, et al. (2003) Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171:3154-3162.
18. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD (2004) Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114:174-182.
19. Orinska Z, et al. (2005) TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106:978-987.
20. Johnsen IB, et al. (2006) Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 25:3335-3346.
21. Hoebe K, et al. (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748.
22. Yamamoto M, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643.
23. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T (2003) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4:161-167.
24. de Bouteiller O, et al. (2005) Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 280:38133-38145.
25. Bell JK, Askins J, Hall PR, Davies DR, Segal DM (2006) The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci USA 103:8792-8797.
26. Leonard JN, Schaffer DV (2006) Antiviral RNAi therapy: emerging approaches for hitting a moving target. Gene Ther 13:532-540.
27. Cain CC, Sipe DM, Murphy RF (1989) Regulation of endocytic pH by the Na+,K+-ATPase in living cells. Proc Natl Acad Sci USA 86:544-548.
28. Sun J, et al. (2006) Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J Biol Chem 281:11144-11151.
29. Takada E, et al. (2007) C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. Mol Immunol 44:3633-3640.
30. Edgcomb SP, Murphy KP (2002) Variability in the pKa of histidine side-chains correlates with burial within proteins. Proteins 49:1-6.
31. Ranjith-Kumar CT, et al. (2007) Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 282:17696-17705.
32. Latz E, et al. (2007) Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8:772-779.
33. Honda K, et al. (2005) Spatiotemporal regulation of MyD88-IRF-7 signaling for robust type-I interferon induction. Nature 434:1035-1040.
34. Barton GM, Kagan JC, Medzhitov R (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49-56.
35. Gay NJ, Gangloff M, Weber AN (2006) Toll-like receptors as molecular switches. Nat Rev Immunol 6:693-698.
36. Qiao M, et al. (2004) Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells. J Infect Dis 190:2104-2108.
37. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV (2005) Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122:169-182.